Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control.
To optimize malaria control, WHO has prioritised the need for new indicators to evaluate the efficacy of malaria vector control strategies. The gSG6-P1 peptide from gSG6 protein of Anopheles gambiae salivary glands was previously designed as a specific salivary sequence of malaria vector species. It...
Main Authors: | Papa Makhtar Drame, Anne Poinsignon, Patrick Besnard, Sylvie Cornelie, Jacques Le Mire, Jean-Claude Toto, Vincent Foumane, Maria Adelaide Dos-Santos, Mbacké Sembène, Filomeno Fortes, Francois Simondon, Pierre Carnevale, Franck Remoue |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3001874?pdf=render |
Similar Items
-
IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to <it>Anopheles </it>bites in urban areas of Dakar region, Sénégal
by: Drame Papa M, et al.
Published: (2012-03-01) -
Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites.
by: Anne Poinsignon, et al.
Published: (2008-06-01) -
Human antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola.
by: Laura Brosseau, et al.
Published: (2012-01-01) -
An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study
by: Berlin Londono-Renteria, et al.
Published: (2015-10-01) -
Variation in exposure to <it>Anopheles gambiae</it> salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands
by: Badu Kingsley, et al.
Published: (2012-09-01)